Home › Funds › GRANDFIELD & DODD, LLC › REGN

GRANDFIELD & DODD, LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

GRANDFIELD & DODD, LLC reported holding 37,098 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$28.1M, representing 1.50% of its reported portfolio and ranking #18 among its reported holdings. GRANDFIELD & DODD, LLC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)37.10K sh
Reported value held$28.13M
Portfolio Weight1.50%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GRANDFIELD & DODD, LLC's REGN position evolved

GRANDFIELD & DODD, LLC first disclosed a stake in REGN in Q3 2023 at 32,242 shares (US$26.5M). The position peaked in Q2 2024 at 32,336 shares, worth US$34.0M. Across 13 filings, GRANDFIELD & DODD, LLC increased the stake 6 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 37,098 shares valued at US$28.1M — an increase of 470 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 32.24K $26.53M New
Q4 2023 32.20K $28.28M Hold
Q1 2024 32.28K $31.07M Hold
Q2 2024 32.34K $33.99M Hold
Q3 2024 32.33K $33.98M Hold
Q4 2024 32.60K $23.22M Add
Q1 2025 33.21K $21.06M Add
Q2 2025 35.20K $18.48M Add
Q3 2025 36.45K $20.50M Add
Q4 2025 36.57K $28.23M Hold
Q1 2026 36.41K $28.14M Hold
Q2 2026 36.63K $22.84M Add
Q3 2026 37.10K $28.13M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has GRANDFIELD & DODD, LLC held REGN?

GRANDFIELD & DODD, LLC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is GRANDFIELD & DODD, LLC's current position in REGN?

As of Q3 2026, GRANDFIELD & DODD, LLC holds 37.10K shares of REGN (REGENERON PHARMACEUTICALS), valued at $28.13M, representing 1.50% of its reported portfolio and ranking #18.

Has GRANDFIELD & DODD, LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), GRANDFIELD & DODD, LLC increased its position in REGN. The position peaked in Q2 2024 at 32.34K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.